| Application no. and date | 10181323.6 (espacenet) (Federated) (European Patent Register), 20020625 | | Patent/reg. no. and date | DK/EP 2270052, 20180328 | | Publication date | 20110105 | | Priority no. and date | US 301172 P, 20010626 | | EP pub. no. and date |
EP 2270052 20110105 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, CA 91320, US,
Amgen Fremont Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | P65101DK01 | | Inventor | CORVALAN, Jose, 125 Williams lane
Foster City, CA 94404, US,
Martin, Francis, 865 Fernhill Court
Newbury Park, CA 91320, US,
Boyle, William, 23629 Malibu Colony Drive
Malibu, CA 90265, US,
Davis, Geoffrey, 1132 Vancouver Avenue
Burlingame, CA 94010, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) , G01N 33/53 (2006.01) , A61P 19/08 (2006.01) | | Title | Antistoffer mod OPGL | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
